Chair in Clinical Pharmacology and Therapeutics, University of Hertfordshire
Professor Schifano is one of the very few physicians with training and specialist qualifications in both psychiatry and clinical pharmacology and has contributed to the biomedical science as well as the clinical science of addiction. He has also made a significant contribution to several areas in addiction psychiatry and general psychiatry, including: stimulant synthetic drugs, mortality studies (Professor Schifano co-supervises and co-leads the National Programme on Substance Abuse Deaths (npSAD)), the internet and drugs. This is a new area of research and Professor Schifano is the Principal Investigator of the third consecutive EU Commission-funded, multi-centre Psychonaut/ReDNet research programme. Results from these studies have provided the only comprehensive and multilingual analysis of the information available online on psychoactive compounds to date.
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Biden administration tells employers to stop shackling workers with ‘noncompete agreements’
Labour can afford to be far more ambitious with its economic policies – voters are on board
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects